Amyris and minerva foods complete joint venture and license agreements to scale low carbon protein production platform

Emeryville, calif., dec. 23, 2021 /prnewswire/ -- amyris, inc. (nasdaq: amrs) ("amyris"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-markettm operating platform, today announced the completion of a previously announced joint venture agreement with mf 92 ventures llc ("minerva"), a minerva foods subsidiary, to develop molecules for the sustainable production and distribution of animal protein ("the joint venture").
AMRS Ratings Summary
AMRS Quant Ranking